Is low albumin (ALB) prognostically significant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low albumin (ALB) levels are prognostically significant and associated with poor outcomes in patients with liver disease, as evidenced by the inclusion of albumin in the Child-Pugh classification and the ALBI score 1. The prognostic significance of low albumin levels is well-established in the context of liver disease, particularly in patients with cirrhosis and hepatocellular carcinoma (HCC).

  • The Child-Pugh classification, which includes albumin as one of its parameters, is widely used to assess liver function and predict outcomes in patients with cirrhosis 1.
  • The ALBI score, which combines albumin and bilirubin, has been shown to stratify patients across different stages of liver disease and predict outcomes 1.
  • Low albumin levels have been associated with increased mortality risk, particularly in elderly populations and those with chronic conditions such as liver disease, heart failure, and kidney disease.
  • The European Association for the Study of the Liver Clinical Practice Guidelines endorse the use of the BCLC classification, which includes liver function, tumor status, and performance status, to guide treatment decisions in patients with HCC 1.
  • While the evidence is not specific to low albumin levels, the inclusion of albumin in these classification systems and scores highlights its importance as a prognostic factor in patients with liver disease.
  • Clinicians should consider evaluating underlying liver disease, malnutrition, or advanced organ dysfunction when encountering low albumin levels, and optimize management of any underlying chronic conditions accordingly.
  • The most recent and highest quality study, published in 2018, provides evidence for the prognostic significance of low albumin levels in patients with HCC 1.

From the Research

Prognostic Significance of Low Albumin (ALB)

  • The provided studies do not directly address the prognostic significance of low albumin (ALB) levels.
  • However, one study 2 mentions low albumin as a factor that is corrected for in a multifactorial model to assess the correlation between low-normal ALT values and increased risk of all-cause mortality.
  • The study found that low-normal ALT values were predictive of increased risk of all-cause mortality, even after correcting for factors such as low albumin, suggesting that low albumin may be associated with poor outcomes.
  • However, this is not a direct assessment of the prognostic significance of low albumin levels, and more research would be needed to fully understand its implications.

Related Biomarkers

  • The studies provided focus on the prognostic significance of alanine aminotransferase (ALT) levels, rather than albumin.
  • Elevated ALT levels are associated with liver injury and disease 3, 4, 5, 6.
  • Low-normal ALT values have been found to be predictive of increased risk of all-cause mortality in middle-aged adults 2.
  • The prognostic significance of low albumin levels is not directly addressed in the provided studies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2009

Research

Serum alanine aminotransferase has limited predictive value for liver disease in chronic hepatitis C.

European review for medical and pharmacological sciences, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.